These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7110964)

  • 1. [Pharmacokinetics of isosorbide dinitrate administered by intravenous infusion to hypertensive patients (author's transl)].
    Frydman A; Levenson J; Simon A; Safar M; Bieder A; Bertharion J; Gaillot J
    Nouv Presse Med; 1982 Jun; 11(27):2049-56. PubMed ID: 7110964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
    Laufen H; Leitold M
    Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of disease, route of administration, cigarette smoking, food intake on the pharmacokinetics and circulatory effects of isosorbide dinitrate.
    Fung HL; Ruggirello D; Stone JA; Parker JO
    Z Kardiol; 1983; 72 Suppl 3():5-10. PubMed ID: 6666234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects.
    Taylor T; Chasseaud LF; Doyle E; Darragh A; O'Kelly DA; Fitzgerald D
    Biopharm Drug Dispos; 1980; 1(3):149-56. PubMed ID: 7448342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of orally given isosorbide dinitrate in cirrhotic patients.
    Bogaert MG; Rosseel MT; Elewaut A
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):491-2. PubMed ID: 6500768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of intravenous infusion of isosorbide dinitrate on hemodynamics during anesthesia and surgery].
    Murakawa T; Ishihara H; Matsuki A; Takazawa T; Kimura K; Maeda A; Wakayama S; Nagao H
    Masui; 1993 Jan; 42(1):71-6. PubMed ID: 8433497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
    Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
    Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and tissue levels of [14C]isosorbide dinitrate after oral and intravenous administration to rat.
    Reed DE; Akester JM; Prather JF; Tuckosh JR; McCurdy DH; Yeh C
    J Pharmacol Exp Ther; 1977 Jul; 202(1):32-7. PubMed ID: 874817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion.
    Santoni Y; Iliadis A; Cano JP; Luccioni R; Frances Y
    J Pharmacokinet Biopharm; 1986 Feb; 14(1):1-17. PubMed ID: 3746630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
    Straehl P; Galeazzi RL; Soliva M
    Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of orally given isosorbide dinitrate in man: factors of variability.
    Bogaert MG; Rosseel MT
    Z Kardiol; 1983; 72 Suppl 3():11-3. PubMed ID: 6141676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic extraction of isosorbide dinitrate in cardiac patients.
    Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Kasper W; Meinertz T; Fung HL
    Clin Pharmacol Ther; 1983 Dec; 34(6):724-31. PubMed ID: 6641086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of isosorbide dinitrate and its main metabolites following oral administration of two sustained release formulations in normal man.
    Gladigau V; Neurath G; Dünger M; Schnelle K; Johnson KI
    Arzneimittelforschung; 1981; 31(5):835-40. PubMed ID: 7196746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of organic nitrates.
    Bogaert MG
    Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma isosorbide dinitrate concentrations and effect after chewable and high-dose, sustained-release formulations.
    Galeazzi RL; Platzer R; Reutemann G
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):387-93. PubMed ID: 6629543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of isosorbide dinitrate.
    Fung HL
    Am Heart J; 1985 Jul; 110(1 Pt 2):213-6. PubMed ID: 4013997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of isosorbide-5-mononitrate after oral and intravenous administration in patients with liver cirrhosis: first results.
    Steudel HC; Volkenandt M; Steudel AT
    Z Kardiol; 1983; 72 Suppl 3():24-8. PubMed ID: 6666228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer.
    Biesma B; Pokorny R; Kovarik JM; Duffy FA; Willemse PH; Mulder NH; de Vries EG
    Cancer Res; 1993 Dec; 53(24):5915-9. PubMed ID: 8261403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.